VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $470,964 | +36.4% | 50,263 | +257.2% | 0.02% | +38.5% |
| Q2 2023 | $345,162 | -85.2% | 14,071 | -86.0% | 0.01% | -86.6% |
| Q1 2023 | $2,337,541 | +129.2% | 100,453 | +149.3% | 0.10% | +79.6% |
| Q4 2022 | $1,019,765 | +214.7% | 40,291 | +139.8% | 0.05% | +315.4% |
| Q3 2022 | $324,000 | -48.4% | 16,800 | -31.2% | 0.01% | -51.9% |
| Q1 2022 | $628,000 | -64.1% | 24,414 | -33.9% | 0.03% | -84.0% |
| Q2 2021 | $1,747,000 | -8.6% | 36,951 | -0.9% | 0.17% | -5.6% |
| Q1 2021 | $1,912,000 | +146.7% | 37,300 | +28.8% | 0.18% | +35.6% |
| Q4 2020 | $775,000 | – | 28,949 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |